Claudio Zamagni | Scholar Profiles and Rankings

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System (journal article) Cecco, Sara \| Puligheddu, Stefano \| Fusaroli, Michele \| Gerratana, Lorenzo \| Yan, Miao \| Zamagni, Claudio \| De Ponti, Fabrizio \| Raschi, Emanuel Targeted Oncology, volume 19, issue 3, pages 435-445 (2024). 10.1007/s11523-024-01058-9 Cited by (2) \| Cite \| Source
Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience (journal article) Starace, Michela \| Rapparini, Luca \| Cedirian, Stephano \| Evangelista, Valeria \| Pampaloni, Francesca \| Bruni, Francesca \| Misciali, Cosimo \| Rubino, Daniela \| Zamagni, Claudio \| Pileri, Alessandro \| Piraccini, Bianca Maria Supportive Care in Cancer, volume 32, issue 3 (2024). 10.1007/s00520-024-08407-4 Cite \| Source
Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs) (journal article) Dri, Arianna \| Arpino, Grazia \| Bianchini, Giampaolo \| Curigliano, Giuseppe \| Danesi, Romano \| De Laurentiis, Michelino \| Del Mastro, Lucia \| Fabi, Alessandra \| Generali, Daniele \| Gennari, Alessandra \| ... \| Puglisi, Fabio Cancer Treatment Reviews, volume 123 (2024). 10.1016/j.ctrv.2023.102672 Cited by (1) \| Cite \| Source
Clonal Hematopoiesis in Whole-Blood and Cell-Free DNA of Ovarian Cancer Patients Undergoing PARP-Inhibitor Treatment: An Exploratory Analysis of the ENGOT-ov48/Eudario Trial (journal article) Arends, Christopher Maximilian \| Kopp, Klara \| Estrada-Barreras, Natalia \| Hablesreiter, Raphael \| Concin, Nicole \| Moll, Ute \| Zeilinger, Robert \| Schmitt, Wolfgang \| Sehouli, Jalid \| Kulbe, Hagen \| ... \| Damm, Frederik Blood, volume 142, issue Supplement 1, pages 1317-1317 (2023). 10.1182/blood-2023-184768 Cite \| Source
Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control (journal article) Ferioli, Martina \| Perrone, Anna M. \| Buwenge, Milly \| Arcelli, Alessandra \| Vadala’, Maria \| Fionda, Bruno \| Malato, Maria C. \| De Iaco, Pierandrea \| Zamagni, Claudio \| Cammelli, Silvia \| ... \| Morganti, Alessio G. Current Oncology, volume 30, issue 11, pages 9895-9905 (2023). 10.3390/curroncol30110719 Cited by (2) \| Cite \| Source
Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper (journal article) Garutti, Mattia \| Cucciniello, Linda \| Arpino, Grazia \| Fabi, Alessandra \| Livi, Lorenzo \| Munzone, Elisabetta \| Staropoli, Nicoletta \| Zamagni, Claudio \| Zambelli, Alberto \| Puglisi, Fabio Clinical Breast Cancer, volume 23, issue 7, pages e458-e469 (2023). 10.1016/j.clbc.2023.07.006 Cited by (4) \| Cite \| Source
267P Pathological complete response after neoadjuvant chemotherapy plus pertuzumab and trastuzumab for HER2+ early breast cancer: Real-world data from NeoPowER study (journal article) Canino, F. \| Barbolini, M. \| De Giorgi, U.F.F. \| Gianni, L. \| Maestri, A. \| Moscetti, L. \| Omarini, C. \| Zamagni, C. \| Costantini, R. Cuoghi \| Tamburrano, F. \| ... \| Piacentini, F. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.464 Cite \| Source
#512 Real-World utilisation and clinical outcomes of patients with BRCA-mutated advanced ovarian cancer treated with olaparib in the first-line maintenance setting: 2-year clinical outcomes of the pan-European OVAL-1 study (conference) Lorusso, Domenica \| Garbay, Delphine \| Roger Asselain, Bernard Jean \| Miller, Rowan \| Raspagliesi, Francesco \| Zamagni, Claudio \| Leary, Alexandra \| Bellier, Charlotte \| Glasspool, Ros \| Jayson, Gordon \| ... \| Gourley, Charlie ESGO 2023 Congress (2023) 10.1136/ijgc-2023-ESGO.895 Cited by (1) \| Cite \| Source
Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis (journal article) Innella, Giovanni \| Godino, Lea \| Erini, Giulia \| De Leo, Antonio \| Santini, Donatella \| Perrone, Anna Myriam \| De Iaco, Pierandrea \| Zamagni, Claudio \| Turchetti, Daniela Journal of Clinical Pathology, volume 76, issue 8, pages 510-517 (2023). 10.1136/jcp-2022-208753 Cite \| Source
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma (journal article) Perrone, Anna Myriam \| Coada, Camelia Alexandra \| Ravegnini, Gloria \| De Leo, Antonio \| Damiano, Giuseppe \| De Crescenzo, Eugenia \| Tesei, Marco \| Di Costanzo, Stella \| Genovesi, Lucia \| Rubino, Daniela \| ... \| De Iaco, Pierandrea International Journal of Gynecologic Cancer, volume 33, issue 8, pages 1270-1278 (2023). 10.1136/ijgc-2022-004249 Cited by (6) \| Cite \| Source
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study) (journal article) Ferioli, Martina \| Benini, Anna \| Malizia, Claudio \| Forlani, Ludovica \| Medici, Federica \| Laghi, Viola \| Ma, Johnny \| Galuppi, Andrea \| Cilla, Savino \| Buwenge, Milly \| ... \| Arcelli, Alessandra Journal of Personalized Medicine, volume 13, issue 8, pages 1229- (2023). 10.3390/jpm13081229 Cited by (4) \| Cite \| Source
A population-based study of BRCA breast cancer incidence and prognosis in the Italian Emilia Romagna region: The MUTina study. (journal article) Cortesi, Laura \| Venturelli, Marta \| Toss, Angela \| Barbieri, Elena \| Musolino, Antonino \| De Giorgi, Ugo \| Bisagni, Giancarlo \| Arcangeli, Valentina \| Zamagni, Claudio \| Cavanna, Luigi \| Dominici, Massimo Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 10616-10616 (2023). 10.1200/JCO.2023.41.16_suppl.10616 Cite \| Source
GLORIOSA: A randomized, open-label, phase 3 study of mirvetuximab soravtansine with bevacizumab vs. bevacizumab as maintenance in platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer. (journal article) O'Malley, David M. \| Myers, Tashanna K. N. \| Zamagni, Claudio \| Diver, Elisabeth \| Lorusso, Domenica Journal of Clinical Oncology, volume 41, issue 16_suppl, pages TPS5622-TPS5622 (2023). 10.1200/JCO.2023.41.16_suppl.TPS5622 Cited by (4) \| Cite \| Source
Clinical activity of camizestrant, a next-generation SERD, versus fulvestrant in patients with a detectable ESR1 mutation: Exploratory analysis of the SERENA-2 phase 2 trial. (journal article) Oliveira, Mafalda \| Pominchuk, Denys \| Hamilton, Erika P. \| Kulyaba, Yaroslav \| Melkadze, Tamar \| Neven, Patrick \| Nemsadze, Gia \| Andabekov, Timur \| Semegen, Yuriy \| Hotko, Yevhen \| ... \| Arkania, Ekaterine Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 1066-1066 (2023). 10.1200/JCO.2023.41.16_suppl.1066 Cited by (7) \| Cite \| Source
199P Correlation of circulating tumor DNA (ctDNA) or thymidine kinase activity (TKa) dynamic patterns with tumor response in patients (pts) with hormone receptor (HR)+ human epidermal growth factor 2 (HER2)– advanced breast cancer (ABC) on ribociclib (RIB (journal article) Arpino, G. \| Bianchini, G. \| Malorni, L. \| Caputo, R. \| Zambelli, A. \| Puglisi, F. \| Del Mastro, L. \| Colleoni, M.A. \| Montemurro, F. \| Bianchi, G.V. \| ... \| De Laurentiis, M. ESMO Open, volume 8, issue 1, pages 101388- (2023). 10.1016/j.esmoop.2023.101388 Cite \| Source
P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial (journal article) Canino, F. \| Barbolini, M. \| De Giorgi, U. \| Dominici, M. \| Gianni, L. \| Moscetti, L. \| Omarini, C. \| Zamagni, C. \| Molinaro, A. \| Antonelli, G. \| ... \| Piacentini, F. The Breast, volume 68 (2023). 10.1016/S0960-9776(23)00237-0 Cite \| Source
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going (journal article) Mazzitelli, Carlotta \| Santini, Donatella \| Corradini, Angelo Gianluca \| Zamagni, Claudio \| Trerè, Davide \| Montanaro, Lorenzo \| Taffurelli, Mario Diagnostics, volume 13, issue 7, pages 1241- (2023). 10.3390/diagnostics13071241 Cited by (7) \| Cite \| Source
Characterization of BRCA Deficiency in Ovarian Cancer (journal article) Barbero, Giovanna \| Zuntini, Roberta \| Magini, Pamela \| Desiderio, Laura \| Bonaguro, Michela \| Perrone, Anna Myriam \| Rubino, Daniela \| Grippa, Mina \| De Leo, Antonio \| Ceccarelli, Claudio \| ... \| Turchetti, Daniela Cancers, volume 15, issue 5, pages 1530- (2023). 10.3390/cancers15051530 Cite \| Source
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival (journal article) Coada, Camelia Alexandra \| Dondi, Giulia \| Ravegnini, Gloria \| Di Costanzo, Stella \| Tesei, Marco \| Fiuzzi, Enrico \| Di Stanislao, Marco \| Giunchi, Susanna \| Zamagni, Claudio \| Bovicelli, Alessandro \| ... \| Perrone, Anna Myriam Journal of Gynecologic Oncology, volume 34, issue 6 (2023). 10.3802/jgo.2023.34.e82 Cited by (3) \| Cite \| Source
TP003/#1533 MITO CERV3_phase II study on carboplatin-paclitaxel-pembrolizumab in neoadjuvant treatment of locally advanced cervical cancer (conference) Salutari, Vanda \| Camarda, Floriana \| Musacchio, Lucia \| Scalone, Simona \| Savarese, Antonella \| Gori, Stefania \| Carbone, Maria Vittoria \| Nero, Camilla \| Vici, Patrizia \| Bergamini, Alice \| ... \| Lorusso, Domenica IGCS 2022 Annual Meeting Abstracts (2022) 10.1136/ijgc-2022-igcs.512 Cite \| Source